This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 23Andme, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Claus Spitzfaden: Innovator in Cancer Treatment
Introduction
Claus Spitzfaden is a notable inventor based in Knebworth, GB. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic proteins.
Latest Patents
One of his key patents is related to Anti-ULBP6 antibodies. This patent discloses a ULBP6 binding protein that inhibits the interaction between ULBP6 and NKG2D. The methods outlined in this patent provide new avenues for treating cancer using the ULBP6 binding protein.
Career Highlights
Claus Spitzfaden is currently associated with 23andMe, Inc., where he continues to work on groundbreaking research. His expertise in the field has led to advancements that could potentially change the landscape of cancer therapies.
Collaborations
He has collaborated with notable colleagues such as Joel Benjamin and Shashank Bharill, contributing to a dynamic research environment that fosters innovation.
Conclusion
Claus Spitzfaden's work exemplifies the impact of innovative thinking in the medical field, particularly in cancer treatment. His contributions through patents and collaborations highlight the importance of research in developing effective therapies.